It has been suggested, on the basis of a previous pilot study conducted in a small number of patients, that MR imaging-based PVE correction in I-123 iomazenil brain SPECT improves the detectability of cortical epileptogenic foci. In the present study, we performed an investigation by using a larger sample size to establish the effectiveness of the PVE correction and to conduct a detailed evaluation based on the histologic classification of lesions.
I
-123 iomazenil brain SPECT is a functional imaging to detect epileptic foci in patients with intractable epilepsy for whom surgical intervention is considered.
1 I-123 iomazenil is specifically bound to central benzodiazepine receptors, 2 whose attenuation or affinity is known to be reduced in epileptogenic foci. 1, 3 In SPECT imaging, therefore, the regional decrease in uptake of I-123 iomazenil indicates the location of epileptogenic foci. Similar findings on I-123 iomazenil SPECT, however, are also observed in brain regions with thin cortical ribbons, gray matter atrophy, or other pathologic brain changes. This limitation is caused by the PVE, which arises from the limited spatial resolution of the scanner. In small structures, the observed radioactivity concentration differs from the true concentration because of blurring of the counts out of the structure ("spill-out") and blurring of the counts into the structure from the surrounding radioactivity ("spill-in"). 4 We have created I-123 iomazenil SPECT images corrected for the whole-brain gray matter volume on the basis of MR imaging measurements in a small number of patients with intractable partial epilepsy and have suggested that the detectability of cortical epileptogenic foci improved in this previous pilot study. 5 In the present study, we carried out the investigation with a much larger number of patients to establish the improvement of foci detectability with I-123 iomazenil SPECT by MR imaging-based PVE correction.
Materials and Methods

Patients
Seventy-five consecutive patients (male/female, 37/38; age, 28 Ϯ 12 years; duration of illness, 17 Ϯ 11 years) at the Shizuoka Institute of Epilepsy and Neurologic Disorder, which is the largest facility for the treatment of and research on intractable epilepsy in Japan, were ret-rospectively enrolled in this study. All the subjects had intractable epilepsy and met the following criteria: 1) no significant morphologic brain lesion that could disturb automatic segmentation or spatial normalization on 3D MR imaging; 2) surgical removal and histopathologic examination of suspected epileptogenic foci performed; 3) I-123 iomazenil brain SPECT and 3D T1-weighted MR imaging studies performed before the operation; and 4) marked improvement of symptoms after surgery, with the seizure outcome at the 2-year follow-up being as good as or better than Engel class II. 6 The rationale for selecting only patients with good surgical outcomes is explained in "Visual Assessment" in this section.
The patient clinical information is summarized in Table 1 . All patients had complex partial seizures with or without generalization and were being treated with anticonvulsants. All patients underwent extracranial scalp video-EEG (interictal and ictal recording) to identify the location and extent of the epileptogenic foci. All the specimens resected during the operations were histopathologically investigated.
The study was approved by the Ethical Committee of Shizuoka Institute of Epilepsy and Neurologic Disorder for clinical research.
SPECT
In each subject, 167 MBq of I-123 iomazenil was intravenously administered. Three hours after the injection, SPECT image acquisition was performed while the subject rested in a quiet room in a supine position on the scanning bed with his or her eyes closed. The SPECT scanning was performed by using a dual-head multigeometry nuclear medicine camera (Millennium VG; GE Healthcare Japan, Tokyo, Japan) with a parallel type collimator (low energy general purpose). The SPECT acquisition protocol was 50 seconds per step, with 36 collections over 360°, and the data were recorded in a 128 ϫ 128 matrix. The raw SPECT data were transferred to a nuclear medicine computer and then processed by Xeleris software (GE Healthcare Japan). The projection data were prefiltered by using a Butterworth filter (cutoff frequency, 0.35 cycles/pixel; order 10) and reconstructed into transaxial sections of 3.16-mm-thick images in planes parallel to the orbitomeatal line. Attenuation correction was performed by using the Chang method 6 with an optimized effective attenuation coefficient of 0.11 cm Ϫ1 .
PVE Correction
PVE correction was performed by using a method similar to that described in our previous pilot study. 5 In this section and in Fig 1, the method for PVE correction and anatomical normalization are briefly described. 3D T1-weighted MR imaging was performed by a Genesis Signa 1.5T scanner (GE Healthcare Japan) by using a fast-spoiled gradient-recalled sequence (TE/TR, 5.15/11.9 ms; flip angle, 20°; acquisition matrix, 256 ϫ 256; section thickness, 2.0 mm). The 3D T1-weighted MR imaging was first segmented into gray matter and other compartments and was then anatomically normalized by using the unified model 8 10 These procedures generated both spatial-normalization matrices and inverse spatial-normalization matrices. The normalized gray matter maps yielded in the above procedures were transformed into native space by using inverse spatial-normalization matrices. The native space gray matter maps thus produced were subsequently binarized (given a value of 0 for the absence of gray matter or 1 for the presence of gray matter), 11 and are referred to as "binarized gray matter maps." The binarized gray matter maps were convoluted with a 3D Gaussian function with a full width at half maximum of 16 ϫ 16 ϫ 16 mm, which was assumed to be the same as the point-spread function of the reconstructed SPECT image, as described in previous studies. 12, 13 The resulting image is subsequently referred to as the "smoothed gray matter map." The SPECT images were coregistered to the smoothed gray matter maps by using the Linear Image Registration Tool of Functional MR Imaging of the Brain (www.fmrib.ox.ac.uk/fsl). 14 The coregistered SPECT image was masked with the binarized gray matter map. The masked SPECT image was then divided by using the smoothed gray matter map on a voxel-by-voxel basis to make the PVE-corrected SPECT image ( Fig  1) . Masking with a binarized gray matter map was performed to prevent irrelevant results caused by division by low gray matter concentration in the regions corresponding to white matter. The SPECT images before and after PVE correction were anatomically normalized by the corresponding spatial-normalization matrices generated in the segmentation and normalization procedure previously mentioned.
Visual Assessment
Six experienced nuclear medicine physicians performed visual assessments of the SPECT images. The physicians were unaware of the patient clinical information to avoid biases caused by differences in the amount of information available for each patient. The physicians visually evaluated the transaxial and/or coronal sections of anatomically normalized I-123 iomazenil SPECT images with and without the PVE correction, presented in a random order, and noted the areas of epileptogenic foci, where the tracer uptake was reduced compared with the corresponding contralateral regions. Decisions regarding the foci were made by joint agreement during a conference of the 6 physicians. Apart from the conference, a brief interobserver reliability test for separate visual assessments by 2 physicians was also performed in the same manner as described.
To identify the resected lesion in the normalized space, an MR image acquired in the stable phase after surgery was first coregistered to the 3D MR image acquired before surgery and was anatomically normalized by the corresponding spatial-normalization matrices generated in the procedure mentioned in the previous section. In the present study, the sensitivity and specificity of the foci detection were determined on a patient-by-patient basis. In the present study, as described under "Patients," only those patients who showed markedly good surgical outcomes were enrolled (Table 1) ; we can assume, therefore, that the resected lesions corresponded to the true epileptogenic foci and that the unresected regions corresponded to the intact brain. Then, a "true-positive " case was defined as a case with visually detected foci in a resected brain region, a "true-negative " case was defined as a case without visually detected foci in an unresected brain region, a "false-positive " case was defined as a case with visually detected foci in an unresected brain region, and a "false-negative case " was defined as a case without visually detected foci in a resected brain region ( Table 2 ). The sensitivity, specificity, and accuracy of uncorrected or PVE-corrected SPECT images were calculated as follows:
sensitivity ϭ number of true-positive cases / total number of patients specificity ϭ number of true-negative cases / total number of patients accuracy ϭ number of cases of true-positive and true-negative at the same time / total number of patients.
Comparison of sensitivity, specificity, and/or accuracy between the uncorrected and the PVE-corrected images was performed by using the McNemar test.
Quantitative Assessment
Quantitative assessment based on asymmetry of the SPECT count in the foci was performed to evaluate the effect of PVE correction. First, the uniform size of the spheric VOI was established and located in the center of the resected lesion in reference to an MR image acquired after the surgery (Fig 2) . For each of these VOIs, the corresponding contralateral congruent VOI was located at the symmetric position based on the Montreal Neurological Institute coordinates. Voxels with zero or negative values were eliminated from the VOI to avoid the pickup of irrelevant voxels. The VOI counts of the uncorrected or the PVE-corrected SPECT images were measured to evaluate the change in asymmetry of the SPECT count in the visually detected epileptogenic foci. The AI for the I-123 iomazenil count of the ipsilateral VOI A C A and that of the contralateral VOI B C B was calculated as follows:
In each case, the CV of the whole brain SPECT counts before and after PVE correction were measured to correct the above-mentioned AI values for the dispersion of voxel values in the whole-brain images. Apart from the foci VOI described above, a whole-brain VOI including only the voxels with positive value in both the uncorrected and the PVE-corrected images was made for each case. As for the uncorrected and PVE-corrected images, CV(%) of the voxel values included in the whole-brain VOI and subsequently AI(%) / CV(%) were calculated. Comparison of AI and/or AI/CV between the uncorrected and the PVE-corrected images was performed by using the Wilcoxon signed rank test.
Results
Visual Assessment
The inter-rater concordance of visual assessment was good; the value was 0.6 for uncorrected SPECT and 0.85 for PVEcorrected SPECT. As a result of visual assessment for change in foci detectability by SPECT PVE correction, sensitivity, specificity, and accuracy were significantly improved for all patients after PVE correction (Table 3 and Fig 3) . For the cases of MTS or tumor, sensitivity and accuracy were significantly improved after PVE correction. Sensitivity and accuracy were significantly improved for the foci in the mesial temporal area after PVE correction. For the foci in the neocortical area, sensitivity, specificity, and accuracy were significantly improved. Sensitivity and accuracy were significantly improved for the patients in the MTS group or for those with tumor after PVE correction. Sensitivity and accuracy were significantly improved by PVE correction for the 23 patients who underwent invasive EEG using depth electrodes and/or subdural electrodes before resection surgery because of inconsistent results of presurgical examinations.
Quantitative Assessment
As a result of quantitative assessment, AIs in foci were significantly increased by SPECT PVE correction in cases with MCD and tumor. AI/CV, moreover, was increased by SPECT PVE correction in the cases with MTS, MCD, and tumor. In cases without abnormal histologic findings except for slight atrophy, on the other hand, no significant changes in AI or AI/CV by PVE correction were observed (Table 4 ).
Discussion
We report that the MR imaging-based PVE correction method for I-123 iomazenil SPECT improved detectability of epileptogenic foci in the present study on the basis of a much larger number of patients than that in our previous pilot study. 7 In this study, foci detectability of uncorrected or PVEcorrected SPECT images was evaluated in each subgroup on the basis of the location or histologic diagnosis of the foci. As a result of visual assessment, PVE correction significantly improved foci detectability of I-123 iomazenil SPECT both in the neocortical and mesial temporal areas. As for specificity of foci detection by SPECT, significant improvement was observed in the neocortical area after PVE correction. This is because PVE tends to be more prominent in the neocortical area under the influence of more complicated and sparser sulcal structures than in the mesial temporal area, and the influence can be effectively removed by PVE correction. In the cases of MTS and of tumor, accuracy of foci detectability was significantly improved by PVE correction. In the cases of MCD, improvement of detectability was remarkable, though it failed to reach significance. This result may be accounted for by the relatively small sample size of the group. For the patient group with no abnormal histologic findings but focal atrophy, on the other hand, foci detectability was not markedly changed by PVE correction. The effect of PVE correction for SPECT on foci detection seems to relate to histologic abnormality of the foci.
One-step surgery for foci resection was performed if the epileptogenic foci were successfully detected on the basis of consistent results of presurgical examinations; otherwise, invasive EEG using depth electrodes and/or subdural electrodes was performed before the resection surgery because of inconsistent results of presurgical examinations. Sensitivity and accuracy of foci detection by uncorrected SPECT were remarkably lower in the latter cases than in the former ones; foci detectability was, on the other hand, significantly improved by PVE correction even in the latter cases. This finding suggests that some of the latter cases could be treated by 1-step surgery without invasive EEG, if the PVE-corrected SPECT was used to detect foci. The AI in the foci was significantly increased by PVE correction for the patient group with MCD and tumor. Increase in AI after PVE correction implies the following 2 factors: One is decrease in the SPECT count in the foci compared with the corresponding contralateral area, and the other is an increase in the volume of the gray matter and/or a decrease in the volume of the adjacent white matter in the lesion areas compared with that in the corresponding contralateral normal areas. 7 In cases of MCD, decrease in inhibitory synaptic connectivity 15 or altered transcription of genes encoding GABAergic receptors 16 has been reported. In a previous study, 17 on the other hand, increase in the regional gray matter concentration in MCD was detected in patients with focal cortical dysplasia by voxel-based morphometry. 18 The case of subcortical heterotopia indicated in Fig 3C is thought to be a representative example. In cases of tumor, underexpressed GABA-receptor signaling in gangliogliomas, 19 (GABA)A-central low benzodiazepine receptor binding in dysembryoplastic neuroepithelial tumors, 20 or a significant decrease in GABAergic-immunoreactive neurons in low-grade gliomas 21 has been reported. As a result of tumor cell proliferation, regional gray matter concentration in the foci is naturally increased in cases of tumor. Thus, in cases of MCD or tumor, our results of analysis for AI change by PVE correction can be accounted for by these findings about central benzodiazepine receptor binding or the results of voxel-based volumetric analysis. In cases of hippocampal sclerosis, attenuation of the central benzodiazepine receptor in the mesial temporal region has been reported to be decreased.
1 Previous voxel-based morphometry studies have demonstrated not only a change of regional gray matter concentration but also a change of regional white matter concen- tration in the mesial temporal area ipsilateral to the foci. A study showed significant increase in gray matter concentration in the ipsilateral temporal area, 18 whereas another study demonstrated decrease in gray matter concentration in a very small area in the ipsilateral mesial temporal lobe by using the optimal voxel-based morphometry method. 22 White matter reduction, on the other hand, was reported in the mesial temporal area ipsilateral to the seizure foci. 23 In the present study, no significant AI change by PVE correction was observed, which seems to reflect the conflicting results of previous studies by volumetric analysis for gray matter concentration in the foci. AI/CV, on the other hand, was significantly increased for all the patient groups with abnormal histologic findings. This finding implies that PVE correction enables the pathologic SPECT-count reduction to be recognized by suppressing apparent fluctuations in the count caused by the distribution of gray matter. This result of quantitative analysis accounts for the improvement of foci detectability by visual assessment. In the cases with no abnormal histologic findings, however, no significant change of AI or AI/CV was found, which is consistent with the results of visual assessment. The present study has some limitations. First, in this study, patients with significant structural abnormalities detected on MR imaging were eliminated to avoid disturbance in automatic segmentation, coregistration, and spatial normalization. Although MR imaging is one of the most reliable modalities for the detection of epileptogenic foci, SPECT may play a more important role in patients with minor structural abnormalities than in those with major structural abnormalities of the brain.
Second, some patients were taking anticonvulsants at the time of their I-123 iomazenil SPECT examination (Table 1) , even though such drugs may influence iomazenil binding to a certain extent. As discussed in our previous study, 7 however, the extent of this influence is rather small.
Third, the method of PVE correction used in this study diminishes anatomic information woven into the original SPECT images, instead of canceling out PVE-related modification of SPECT counts. To compensate for this problem, we normalized all the images to the common Montreal Neurological Institute template. For clinical use, however, it may be necessary to refer to the coregistered MR imaging.
Fourth, because all subjects were patients with epileptogenic lesions, it would seem difficult to assess the absolute ability, per se, of I-123 iomazenil SPECT to exclude normal asymmetry of central benzodiazepine receptor binding. We have also performed an asymmetry analysis of normal central benzodiazepine receptor binding, and the report is currently under preparation.
Fifth, the present study is a retrospective one, which is inevitably affected by the bias of patient selection for analysis. We have already started a prospective study in major institutions in Japan that are treating large numbers of patients with intractable epilepsy.
Sixth, the MR imaging-based PVE correction scheme applied here is known to be sensitive to the effects of misregistration and mis-segmentation, 24 though, at poor spatial resolution like SPECT, the impact of these effects on PVE correction is relatively small. 25 To date, several methods to correct for PVEs have been proposed. 24, 26, 27 Among these, the voxel-based and MR imaging-based PVE correction scheme is the most feasible for operative clinical implementation because it is simple, less time consuming, and suitable for visual detection of the foci in the whole range of cerebral cortices; moreover, MR imaging examinations are routinely executed for presurgical diagnosis of epileptogenic foci in most cases of intractable epilepsy.
Conclusions
In the present study, we established the effectiveness of MR imaging-based PVE correction in I-123 iomazenil brain SPECT in improving the detection of cortical epileptogenic foci with abnormal histologic findings by investigation of a large number of patients with intractable partial epilepsy and suggest the possibility that a more invasive examination could be avoided in some cases by the use of this technique.
